| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |